Pharma & Healthcare

Global Injections for SMA Market Research Report 2026

This report delivers a comprehensive overview of the global Injections for SMA market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Injections for SMA. The Injections for SMA market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Injections for SMA market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Injections for SMA manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Biogen
Ionis Pharmaceuticals
Segment by Type
Antisense Oligonucleotides
Gene Therapy
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Injections for SMA manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Injections for SMA sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Injections for SMA Market Overview
1.1 Product Definition
1.2 Injections for SMA by Type
1.2.1 Global Injections for SMA Market Value by Type: 2025 vs 2032
1.2.2 Antisense Oligonucleotides
1.2.3 Gene Therapy
1.3 Injections for SMA by Application
1.3.1 Global Injections for SMA Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Injections for SMA Market Size Estimates and Forecasts
1.4.1 Global Injections for SMA Revenue 2021–2032
1.4.2 Global Injections for SMA Sales 2021–2032
1.4.3 Global Injections for SMA Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Injections for SMA Market Competition by Manufacturers
2.1 Global Injections for SMA Sales Market Share by Manufacturers (2021–2026)
2.2 Global Injections for SMA Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Injections for SMA Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Injections for SMA, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Injections for SMA, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Injections for SMA, Product Types and Applications
2.7 Global Key Manufacturers of Injections for SMA, Date of Entry into the Industry
2.8 Global Injections for SMA Market Competitive Situation and Trends
2.8.1 Global Injections for SMA Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Injections for SMA Players Market Share by Revenue
2.8.3 Global Injections for SMA Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injections for SMA Market Scenario by Region
3.1 Global Injections for SMA Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Injections for SMA Sales by Region: 2021–2032
3.2.1 Global Injections for SMA Sales by Region: 2021–2026
3.2.2 Global Injections for SMA Sales by Region: 2027–2032
3.3 Global Injections for SMA Revenue by Region: 2021–2032
3.3.1 Global Injections for SMA Revenue by Region: 2021–2026
3.3.2 Global Injections for SMA Revenue by Region: 2027–2032
3.4 North America Injections for SMA Market Facts & Figures by Country
3.4.1 North America Injections for SMA Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Injections for SMA Sales by Country (2021–2032)
3.4.3 North America Injections for SMA Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injections for SMA Market Facts & Figures by Country
3.5.1 Europe Injections for SMA Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Injections for SMA Sales by Country (2021–2032)
3.5.3 Europe Injections for SMA Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injections for SMA Market Facts & Figures by Region
3.6.1 Asia Pacific Injections for SMA Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Injections for SMA Sales by Region (2021–2032)
3.6.3 Asia Pacific Injections for SMA Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injections for SMA Market Facts & Figures by Country
3.7.1 Latin America Injections for SMA Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Injections for SMA Sales by Country (2021–2032)
3.7.3 Latin America Injections for SMA Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injections for SMA Market Facts & Figures by Country
3.8.1 Middle East and Africa Injections for SMA Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Injections for SMA Sales by Country (2021–2032)
3.8.3 Middle East and Africa Injections for SMA Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injections for SMA Sales by Type (2021–2032)
4.1.1 Global Injections for SMA Sales by Type (2021–2026)
4.1.2 Global Injections for SMA Sales by Type (2027–2032)
4.1.3 Global Injections for SMA Sales Market Share by Type (2021–2032)
4.2 Global Injections for SMA Revenue by Type (2021–2032)
4.2.1 Global Injections for SMA Revenue by Type (2021–2026)
4.2.2 Global Injections for SMA Revenue by Type (2027–2032)
4.2.3 Global Injections for SMA Revenue Market Share by Type (2021–2032)
4.3 Global Injections for SMA Price by Type (2021–2032)
5 Segment by Application
5.1 Global Injections for SMA Sales by Application (2021–2032)
5.1.1 Global Injections for SMA Sales by Application (2021–2026)
5.1.2 Global Injections for SMA Sales by Application (2027–2032)
5.1.3 Global Injections for SMA Sales Market Share by Application (2021–2032)
5.2 Global Injections for SMA Revenue by Application (2021–2032)
5.2.1 Global Injections for SMA Revenue by Application (2021–2026)
5.2.2 Global Injections for SMA Revenue by Application (2027–2032)
5.2.3 Global Injections for SMA Revenue Market Share by Application (2021–2032)
5.3 Global Injections for SMA Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Injections for SMA Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Injections for SMA Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Biogen
6.2.1 Biogen Company Information
6.2.2 Biogen Description and Business Overview
6.2.3 Biogen Injections for SMA Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Biogen Injections for SMA Product Portfolio
6.2.5 Biogen Recent Developments/Updates
6.3 Ionis Pharmaceuticals
6.3.1 Ionis Pharmaceuticals Company Information
6.3.2 Ionis Pharmaceuticals Description and Business Overview
6.3.3 Ionis Pharmaceuticals Injections for SMA Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Ionis Pharmaceuticals Injections for SMA Product Portfolio
6.3.5 Ionis Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injections for SMA Industry Chain Analysis
7.2 Injections for SMA Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injections for SMA Production Mode & Process Analysis
7.4 Injections for SMA Sales and Marketing
7.4.1 Injections for SMA Sales Channels
7.4.2 Injections for SMA Distributors
7.5 Injections for SMA Customer Analysis
8 Injections for SMA Market Dynamics
8.1 Injections for SMA Industry Trends
8.2 Injections for SMA Market Drivers
8.3 Injections for SMA Market Challenges
8.4 Injections for SMA Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Injections for SMA Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injections for SMA Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injections for SMA Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injections for SMA Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Injections for SMA Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injections for SMA Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injections for SMA Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injections for SMA Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injections for SMA, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injections for SMA, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injections for SMA, Product Types and Applications
Table 12. Global Key Manufacturers of Injections for SMA, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injections for SMA Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injections for SMA Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injections for SMA Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injections for SMA Sales by Region (K Units), 2021–2026
Table 18. Global Injections for SMA Sales Market Share by Region (2021–2026)
Table 19. Global Injections for SMA Sales by Region (K Units), 2027–2032
Table 20. Global Injections for SMA Sales Market Share by Region (2027–2032)
Table 21. Global Injections for SMA Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injections for SMA Revenue Market Share by Region (2021–2026)
Table 23. Global Injections for SMA Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injections for SMA Revenue Market Share by Region (2027–2032)
Table 25. North America Injections for SMA Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injections for SMA Sales by Country (K Units), 2021–2026
Table 27. North America Injections for SMA Sales by Country (K Units), 2027–2032
Table 28. North America Injections for SMA Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injections for SMA Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injections for SMA Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injections for SMA Sales by Country (K Units), 2021–2026
Table 32. Europe Injections for SMA Sales by Country (K Units), 2027–2032
Table 33. Europe Injections for SMA Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injections for SMA Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injections for SMA Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injections for SMA Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Injections for SMA Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Injections for SMA Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injections for SMA Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injections for SMA Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injections for SMA Sales by Country (K Units), 2021–2026
Table 42. Latin America Injections for SMA Sales by Country (K Units), 2027–2032
Table 43. Latin America Injections for SMA Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injections for SMA Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injections for SMA Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injections for SMA Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Injections for SMA Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Injections for SMA Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injections for SMA Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injections for SMA Sales (K Units) by Type (2021–2026)
Table 51. Global Injections for SMA Sales (K Units) by Type (2027–2032)
Table 52. Global Injections for SMA Sales Market Share by Type (2021–2026)
Table 53. Global Injections for SMA Sales Market Share by Type (2027–2032)
Table 54. Global Injections for SMA Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injections for SMA Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injections for SMA Revenue Market Share by Type (2021–2026)
Table 57. Global Injections for SMA Revenue Market Share by Type (2027–2032)
Table 58. Global Injections for SMA Price (US$/Unit) by Type (2021–2026)
Table 59. Global Injections for SMA Price (US$/Unit) by Type (2027–2032)
Table 60. Global Injections for SMA Sales (K Units) by Application (2021–2026)
Table 61. Global Injections for SMA Sales (K Units) by Application (2027–2032)
Table 62. Global Injections for SMA Sales Market Share by Application (2021–2026)
Table 63. Global Injections for SMA Sales Market Share by Application (2027–2032)
Table 64. Global Injections for SMA Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injections for SMA Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injections for SMA Revenue Market Share by Application (2021–2026)
Table 67. Global Injections for SMA Revenue Market Share by Application (2027–2032)
Table 68. Global Injections for SMA Price (US$/Unit) by Application (2021–2026)
Table 69. Global Injections for SMA Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis Injections for SMA Product
Table 74. Novartis Recent Developments/Updates
Table 75. Biogen Company Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Biogen Injections for SMA Product
Table 79. Biogen Recent Developments/Updates
Table 80. Ionis Pharmaceuticals Company Information
Table 81. Ionis Pharmaceuticals Description and Business Overview
Table 82. Ionis Pharmaceuticals Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Ionis Pharmaceuticals Injections for SMA Product
Table 84. Ionis Pharmaceuticals Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Injections for SMA Distributors List
Table 88. Injections for SMA Customers List
Table 89. Injections for SMA Market Trends
Table 90. Injections for SMA Market Drivers
Table 91. Injections for SMA Market Challenges
Table 92. Injections for SMA Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report


List of Figures
Figure 1. Product Picture of Injections for SMA
Figure 2. Global Injections for SMA Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injections for SMA Market Share by Type: 2025 & 2032
Figure 4. Antisense Oligonucleotides Product Picture
Figure 5. Gene Therapy Product Picture
Figure 6. Global Injections for SMA Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Injections for SMA Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Injections for SMA Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Injections for SMA Market Size (US$ Million), 2021–2032
Figure 13. Global Injections for SMA Sales (K Units), 2021–2032
Figure 14. Global Injections for SMA Average Price (US$/Unit), 2021–2032
Figure 15. Injections for SMA Report Years Considered
Figure 16. Injections for SMA Sales Share by Manufacturers in 2025
Figure 17. Global Injections for SMA Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Injections for SMA Players: Market Share by Revenue in Injections for SMA in 2025
Figure 19. Injections for SMA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Injections for SMA Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Injections for SMA Sales Market Share by Country (2021–2032)
Figure 22. North America Injections for SMA Revenue Market Share by Country (2021–2032)
Figure 23. United States Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Injections for SMA Sales Market Share by Country (2021–2032)
Figure 26. Europe Injections for SMA Revenue Market Share by Country (2021–2032)
Figure 27. Germany Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Injections for SMA Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Injections for SMA Revenue Market Share by Region (2021–2032)
Figure 34. China Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Injections for SMA Sales Market Share by Country (2021–2032)
Figure 42. Latin America Injections for SMA Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Injections for SMA Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Injections for SMA Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Injections for SMA Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Injections for SMA by Type (2021–2032)
Figure 53. Global Revenue Market Share of Injections for SMA by Type (2021–2032)
Figure 54. Global Injections for SMA Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Injections for SMA by Application (2021–2032)
Figure 56. Global Revenue Market Share of Injections for SMA by Application (2021–2032)
Figure 57. Global Injections for SMA Price (US$/Unit) by Application (2021–2032)
Figure 58. Injections for SMA Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies